Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Information Procurement
1.2.1. Purchased database
1.2.2. Internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information Analysis
1.3.1. Data analysis models
1.4. Market Formulation & Data Visualization
1.5. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Anesthesia and Respiratory Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. User Perspective Analysis
3.4.1. Consumer behavior analysis
3.4.2. Market influencer analysis
3.5. List of Key End-users, by Region/by Country/by Product
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & compliances
3.7. Market Dynamics
3.7.1. Market driver analysis
3.7.1.1. Shifting patient preference towards reduced hospital stay
3.7.1.2. Supportive government funding in emerging markets
3.7.1.3. Increasing global geriatric population base
3.7.1.4. Technological advancements
3.7.2. Market restraint analysis
3.7.2.1. Lack of patient compliance
3.7.2.2. Economic impact of respiratory disorders
3.7.3. Industry challenges
3.7.3.1.Harmful effects of the respiratory devices on neonates
3.8. Anesthesia and respiratory devices: Market Analysis Tools
3.8.1. Industry analysis - Porter’s
3.8.1.1. Supplier power: (Moderate): Presence of various major raw material suppliers
3.8.1.2. Buyer power: (Moderate): Existence of insurance agencies focusing on cost reduction is expected to result in the consolidation
3.8.1.3. Substitution threat: (Moderate): Introduction of technological advanced products
3.8.1.4. Threat from new entrant: (Moderate): Complying with various regulatory bodies
3.8.1.5. Competitive rivalry: (High): Dominated by few major players
3.8.2. PESTEL analysis
3.8.2.1 .Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major deals & strategic alliances analysis
3.8.3.1. Joint ventures
3.8.3.2. Mergers & acquisitions
3.8.3.3. Licensing & partnership
3.8.3.4. Technology collaborations
3.8.3.5. Strategic divestments
3.8.4. Market entry strategies
Chapter 4. Anesthesia and respiratory devices Market: Segment Analysis, By Product, 2015 - 2026 (USD Million)
4.1. Definitions & Scope
4.2. Product Market Share Analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Anesthesia and respiratory devices Market, by Product, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Anesthesia devices
4.5.1.1. Anesthesia machines
4.5.1.1.1. Anesthesia workstation
4.5.1.1.2. Anesthesia delivery machines
4.5.1.1.2.1. PorTable
4.5.1.1.2.2. Standalone
4.5.1.1.3. Anesthesia ventilators
4.5.1.1.4. Anesthesia monitors
4.5.1.2. Anesthesia disposables
4.5.1.2.1. Anesthesia masks
4.5.1.2.2. Anesthesia accessories
4.5.2. Respiratory devices
4.5.2.1. Respiratory equipment
4.5.2.1.1. Humidifiers
4.5.2.1.1.1. Heat humidifiers
4.5.2.1.1.2. Heated wire breathing circuits
4.5.2.1.1.3. Heat exchangers
4.5.2.1.1.4. Pass over humidifiers
4.5.2.1.2. Nebulizers
4.5.2.1.2.1. Pneumatic nebulizers
4.5.2.1.2.2. Mesh nebulizers
4.5.2.1.2.3. Ultrasonic nebulizers
4.5.2.1.3. Oxygen concentrator
4.5.2.1.3.1. Fixed oxygen concentrators
4.5.2.1.3.2. PorTable oxygen concentrators
4.5.2.1.4. Positive airway pressure devices
4.5.2.1.4.1. Bi-level positive airway pressure devices
4.5.2.1.4.2. Continuous positive airway pressure devices
4.5.2.1.5. Reusable resuscitators
4.5.2.1.6. Ventilators
4.5.2.1.6.1. Adult ventilators
4.5.2.1.6.2. Neonatal ventilators
4.5.2.1.7. Respiratory inhalers
4.5.2.1.7.1. Dry powdered inhaler
4.5.2.1.7.2. Metered dose inhaler
4.5.2.2. Respiratory disposables
4.5.2.2.1. Disposable oxygen masks
4.5.2.2.2. Resuscitators
4.5.2.2.3. Tracheotomy Tubes
4.5.2.2.4. Oxygen Cannula
4.5.2.3. Respiratory measurement devices
4.5.2.3.1. Pulse oximetry systems
4.5.2.3.2. Capnographs
4.5.2.3.3. Spirometers
4.5.2.3.4. Peak flowmeters
Chapter 5. Anesthesia and Respiratory Devices Market: Regional Market Analysis, By Region, 2015 - 2026 (USD Million)
5.1. Definitions & Scope
5.2. Regional Market Share Analysis, 2018 & 2026
5.3. Regional Market Dashboard
5.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
5.5. Regional Market Share and Leading Players, 2018
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
5.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
5.7. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2025:
5.8. North America
5.8.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.8.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.8.3. U.S.
5.8.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.8.4. Canada
5.8.4.1.Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9. Europe
5.9.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.9.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9.3. Germany
5.9.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9.4. U.K.
5.9.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9.5. Italy
5.9.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9.6. France
5.9.6.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9.7. Spain
5.9.7.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10. Asia Pacific
5.10.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.10.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10.3. India
5.10.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10.4. China
5.10.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10.5. Japan
5.10.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10.6. Australia
5.10.6.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10.7. South Korea
5.10.7.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.11. Latin America
5.11.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.11.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.11.3. Brazil
5.11.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.11.4. Mexico
5.11.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.11.5. Argentina
5.11.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.11.6. Colombia
5.11.6.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.12. Middle East and Africa
5.12.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.12.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.12.3. South Africa
5.12.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.12.4. Saudi Arabia
5.12.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.12.5. UAE
5.12.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
Chapter 6. Anesthesia and Respiratory Devices Market - Competitive Analysis
6.1. Recent Developments & Impact Analysis, by Key Market Participants
6.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2018
6.4. Public Companies
6.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
6.4.2. Company market share/ranking, by region
6.4.3. Competitive dashboard analysis
6.4.3.1. Market differentiators
6.4.3.2. Synergy analysis: Major deals & strategic alliances
6.5. Private Companies
6.5.1. List of key emerging companies/technology disruptors/innovators
6.5.2. Funding outlook (Optional)
6.5.3. Regional network map
6.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
6.6. Supplier Ranking
6.7. Key Companies Profiled
6.7.1. GE Healthcare
6.7.1.1. Company overview
6.7.1.2. Financial performance
6.7.1.3. Product benchmarking
6.7.1.4. Strategic initiatives
6.7.2. Medtronic Plc
6.7.2.1. Company overview
6.7.2.2. Financial performance
6.7.2.3. Product benchmarking
6.7.2.4. Strategic initiatives
6.7.3. Teleflex Incorporated
6.7.3.1. Company overview
6.7.3.2. Financial performance
6.7.3.3. Product benchmarking
6.7.3.4. Strategic initiatives
6.7.4. Philips Healthcare
6.7.4.1. Company overview
6.7.4.2. Financial performance
6.7.4.3. Product benchmarking
6.7.4.4. Strategic initiatives
6.7.5. Drägerwerk AG & Co. KGaA
6.7.5.1. Company overview
6.7.5.2. Financial performance
6.7.5.3. Product benchmarking
6.7.5.4. Strategic initiatives
6.7.6. Getinge AB
6.7.6.1. Company overview
6.7.6.2. Financial performance
6.7.6.3. Product benchmarking
6.7.6.4. Strategic initiatives
6.7.7. Smiths Group Plc
6.7.7.1. Company overview
6.7.7.2. Financial performance
6.7.7.3. Product benchmarking
6.7.7.4. Strategic initiatives
6.7.8. Fisher & Paykel Healthcare Limited
6.7.8.1. Company overview
6.7.8.2. Financial performance
6.7.8.3. Product benchmarking
6.7.8.4. Strategic initiatives
6.7.9. Masimo Corporation
6.7.9.1. Company overview
6.7.9.2. Financial performance
6.7.9.3. Product benchmarking
6.7.9.4. Strategic initiatives
6.7.10. B. Braun Melsungen AG
6.7.10.1. Company overview
6.7.10.2. Financial performance
6.7.10.3. Product benchmarking
6.7.10.4. Strategic initiatives
6.7.11. ResMed
6.7.11.1. Company overview
6.7.11.2. Financial performance
6.7.11.3. Product benchmarking
6.7.11.4. Strategic initiatives
6.7.12. Charts Industries
6.7.12.1. Company overview
6.7.12.2. Financial performance
6.7.12.3. Product benchmarking
6.7.12.4. Strategic initiatives
